Entera Bio (ENTX) Insider Trading & Ownership $1.82 +0.02 (+1.11%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.84 +0.01 (+0.82%) As of 08/8/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Entera Bio (NASDAQ:ENTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.38%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$128.97KNumber OfInsiders Selling(Last 3 Years)0 Get ENTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Entera Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ENTX Insider Buying and Selling by Quarter Entera Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/12/2024Haya TaitelDirectorBuy9,500$0.99$9,405.00 1/10/2024Haya TaitelDirectorBuy7,615$0.77$5,863.55 12/22/2023Miranda Jayne ToledanoCEOBuy23,952$0.71$17,005.92 8/21/2023Sean EllisDirectorBuy40,000$0.60$24,000.00 4/4/2023Miranda Jayne ToledanoCEOBuy30,000$1.01$30,300.00 11/11/2022Miranda Jayne ToledanoCEOBuy50,000$0.53$26,500.00 11/11/2022Sean EllisDirectorBuy30,000$0.53$15,900.00 (Data available from 1/1/2013 forward) ENTX Insider Trading Activity - Frequently Asked Questions Who is on Entera Bio's Insider Roster? The list of insiders at Entera Bio includes Haya Taitel, Miranda Jayne Toledano, and Sean Ellis. Learn more on insiders at ENTX. What percentage of Entera Bio stock is owned by insiders? 10.38% of Entera Bio stock is owned by insiders. Learn more on ENTX's insider holdings. Which Entera Bio insiders have been buying company stock? The following insiders have purchased ENTX shares in the last 24 months: Haya Taitel ($15,268.55), Miranda Jayne Toledano ($17,005.92), and Sean Ellis ($24,000.00). How much insider buying is happening at Entera Bio? Insiders have purchased a total of 81,067 ENTX shares in the last 24 months for a total of $56,274.47 bought. Entera Bio Key ExecutivesMs. Miranda J. Toledano M.B.A. (Age 47)CEO & Director Compensation: $418kMs. Dana Yaacov-Garbeli CPA (Age 41)Chief Financial Officer Compensation: $193kDr. Hillel Galitzer M.B.A. (Age 46)Ph.D., Chief Operating Officer Compensation: $296kDr. Arthur C. Santora II (Age 73)M.D., Ph.D., Chief Medical Officer Compensation: $355k More Insider Trading Tools from MarketBeat Related Companies Rocket Pharmaceuticals Insider Trading Inhibrx Biosciences Insider Trading Abeona Therapeutics Insider Trading Atea Pharmaceuticals Insider Trading Altimmune Insider Trading Allogene Therapeutics Insider Trading ADC Therapeutics Insider Trading Neurogene Insider Trading Capricor Therapeutics Insider Trading Olema Pharmaceuticals Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:ENTX) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredChina's 500 Million Year AdvantageThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
